Global Biosimilars Market

Market Dynamics

The Global Biosimilars Market was currently valued at $5237.0 and is projected to grow at CAGR of 40.3% during the forecast period, reaching $28200.0 million by 2020.

The factors that are fuelling the growth of this market include increasing need for cost-effective drugs, increasing number of patents expiring in the near future accounting for approximate sales of $9.1 billion, intended reductions in the healthcare expenditure and cost-effectiveness of biosimilar drugs. Other than these, the increasing demand for biosimilars is another driving force for this market.

However, there are some factors that restrain the growth of this market, such as different regulatory frameworks in different countries, high manufacturing complexities and varying technologies. Also there are complexities related to scaling up of operations.

Market Segmentation

Global biosimilars market can be segmented as follows :

Segmentation by application includes - Chronic and autoimmune diseases, Blood disorders, Growth hormone deficiency diseases and Oncology. The blood disorders segment dominates the market accounting for more than 55% of the share.

Segmentation by end user involves Retail pharmacies and Hospitals. The retail pharmacies segment lead the global biosimilars market with 52% market share.

Regional/Geographic Analysis

In terms of geography, EMEA was the region contributing with the highest revenue in the global biosimilars market and is expected to reach to approx.. $5 billion by 2020. The market will witness high growth in countries such as the France, Spain, UK, Germany and Italy. The biosimilars market in UK is mature and well-established, making the generic drugs market more stronger. The growth in this area is attributed to well-defined regulatory frameworks.

Key Players

The major players in the global biosimilars market are Sandoz, Dr. Reddys, Accord Healthcare, Apotex, Teva Pharmaceuticals, Hospira, Bioton, Eli Lilly, Biocon, Sun-Ranbaxy, Zydus Cadila, Hexal, Synthon, and Celltrion.

Report Contents:

> Market segments

> Market Drivers, Restraints and Opportunities

> Market Size & Forecast 2016 to 2022

> Supply & Demand Value Chain

> Market - Current Trends

> Competition & Major Companies

> Technology and R&D Status

> Porters Five Force Analysis

> Strategic and Critical Success Factor Analysis of Key Players

Regional Analysis:

> North America

>> US and Canada

> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America

> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)

>> Nordic Countries (Denmark, Finland, Norway, and Sweden)

>> Benelux (Belgium, The Netherlands, and Luxembourg)

>> Rest of Western Europe

> Eastern Europe

>> Russia

>> Poland

>> Rest of Eastern Europe

> Asia Pacific

>> China

>> India

>> Japan

>> Australia and New Zealand

>> Rest of Asia Pacific

> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)

>> South Africa

>> North Africa

>> Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.

Report Highlights:

> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)

> Consumer and Pricing Analysis

> Market dynamics of the industry

> Market Segmentation

> Estimated Market Sizing in terms of volume and value

> Recent trends in Market and impact

> Research Status and Technology Overview

> Extensive Industry Structure Coverage